Breast Cancer
Research led by Mayo Clinic oncologists Roberto A. Leon Ferre, M.D., and Charles L. Loprinzi, M.D., has found that the drug oxybutynin helps reduce the[...]
A less-invasive nipple-sparing mastectomy that leaves the surface of the breast intact has become a safe option for more patients, including those whose breast cancer[...]
Treating breast cancer has long involved addressing two problems: the elimination of cancer cells from the tumor and potential disease recurrence. The key may be[...]
Keith L. Knutson, Ph.D., an immunologist at Mayo Clinic's campus in Florida and a professor in the Mayo Clinic College of Medicine and Science, discusses his research on the immunology and immunotherapy of breast cancer and ovarian cancer.